Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.7 USD | -2.18% | +10.88% | +46.73% |
May. 31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.73% | 942M | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+2.39% | 22.42B | |
-12.11% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Wedbush Raises Immunome's PT to $27 From $19 on Heels of Announced Plans to Acquire AL101, AL102 From Ayala Pharmaceuticals; Keeps Outperform Rating